E-ISSN 2149-388X | ISSN 2149-0430
 
2025, Vol: 11, Issue: 1
11 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Letter to the Editor 


High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging

Sevin Ayaz.


Abstract
Though 18F-FDG uptake due to benign pathologies is usually less than that of the malignant tumors, some overlap can occur between these two distinct entities. In order to differentiate benign FDG uptake from malignant, the image interpreter should get a detailed patient history (surgical and clinical history, previous and recent therapies, history of trauma etc.) and evaluate all the previously obtained radiological and scintigraphic images of the patient. In case of a need, laboratory tests and/or other imaging methods such as ultrasonography and MRI should be performed, in accordance with other disciplines. Stability of these lesions on follow-up scans is an important clue for benignity.

Key words: 18F-FDG Uptake, Benign Pathologies, Oncological PET/CT Imaging


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sevin Ayaz
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Sevin Ayaz. High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging. Ulutas Med J. 2017; 3(3): 57-58. doi:10.5455/umj.20170312084153

Web Style

Sevin Ayaz. High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging. https://www.ulutasmedicaljournal.com/?mno=260269 [Access: March 15, 2025]. doi:10.5455/umj.20170312084153

AMA (American Medical Association) Style

Sevin Ayaz. High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging. Ulutas Med J. 2017; 3(3): 57-58. doi:10.5455/umj.20170312084153


Vancouver/ICMJE Style

Sevin Ayaz. High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging. Ulutas Med J. (2017), [cited March 15, 2025]; 3(3): 57-58. doi:10.5455/umj.20170312084153


Harvard Style

Sevin Ayaz (2017) High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging. Ulutas Med J, 3 (3), 57-58. doi:10.5455/umj.20170312084153


Turabian Style

Sevin Ayaz. 2017. High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging. THE ULUTAS MEDICAL JOURNAL, 3 (3), 57-58. doi:10.5455/umj.20170312084153


Chicago Style

Sevin Ayaz. "High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging." THE ULUTAS MEDICAL JOURNAL 3 (2017), 57-58. doi:10.5455/umj.20170312084153


MLA (The Modern Language Association) Style

Sevin Ayaz. "High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging." THE ULUTAS MEDICAL JOURNAL 3.3 (2017), 57-58. Print. doi:10.5455/umj.20170312084153


APA (American Psychological Association) Style

Sevin Ayaz (2017) High 18F-FDG Uptake in Benign Pathologies: A Challenge in Oncological PET/CT Imaging. THE ULUTAS MEDICAL JOURNAL, 3 (3), 57-58. doi:10.5455/umj.20170312084153


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writing a research pap ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.